Edition:
United Kingdom

Adamis Pharmaceuticals gets FDA approval for co's epinephrine pre-filled syringe


Thursday, 15 Jun 2017 

June 15 (Reuters) - Adamis Pharmaceuticals Corp ::Adamis pharmaceuticals receives FDA approval for its epinephrine pre-filled syringe.Adamis pharmaceuticals receives FDA approval for its epinephrine pre-filled syringe.FDA has also approved PFS trade name of Symjepi.‍FDA approved Adamis' epinephrine injection, USP, 1:1000 for emergency treatment of allergic reactions including anaphylaxis​.Are preparing to submit second NDA for junior version of Symjepi to FDA.Expect to build inventory levels in preparation for anticipated launch in H2 of year for co's epinephrine pre-filled syringe.